Doxycycline hyclate controlled release - POLYPID
Alternative Names: D-PLEX; D-PLEX-100; Doxycycline/polymer-lipid encapsulation matrix; PLEX-doxycyclineLatest Information Update: 19 Jun 2025
At a glance
- Originator POLYPID
- Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Surgical wound infections
Most Recent Events
- 09 Jun 2025 Efficacy data from the phase III SHIELD II trial in Surgical wound infections released by POLYPID
- 14 May 2025 PolyPid plans for the submission of a Marketing Authorisation Application (MAA) for Surgical wound infections to the European Union in 2026
- 14 May 2025 PolyPid plans to submit a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Surgical wound infections in early 2026